PATENT CLAIM ANALYSIS

Application Number: 15770444
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "560000"]

Abstract:
The invention relates to a composition comprising) (i) one or more ω-3 fatty acids selected from the group consisting of DHA, DPA and EPA and (ii) one or more pyrimidine derivatives selected from the group consisting of uridine sources and cytidine sources for use in decreasing or normalizing the phenyl alanine level in the blood of a PKU patient or for use in dietary management of phenylalanine levels in the blood of a PKU patient.

Claim (Index 19):
The nutritional composition according to  claim 15 , comprising\n i) DHA and EPA ii) uridine and/or uridine monophosphate iii) at least one vitamin B selected from the group consisting of vitamin B6, vitamin B9 and vitamin B12 iv) phosphatidylcholine and/or one or more other phospholipids; and v) an antioxidant selected from the group consisting of vitamin C, vitamin E and selenium.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 91.0
- Lexical Diversity: 1.67347
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14784838', '15770116', '13977162', '15102136', '14005098']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7753940312417116
- 35 USC 102 Novelty (BERT): 0.5518301244579059
- Combined Prediction Score: 0.753037640563331
- Mean Citation Score: 324.68270199999995
- Max Citation Score: 423.5979
- Similarity Product: 336.93705113765

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test